Bank Of Montreal Milestone Pharmaceuticals Inc. Transaction History

Bank Of Montreal

  • $214 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$1.4 - $2.2 $382,340 - $600,820
273,100 New
273,100 $488,000
Q4 2022

Feb 01, 2023
BUY
$3.53 - $9.5 $369,012 - $993,092
104,536 Added 217.33%
152,636 $604,000
Q3 2022

Nov 10, 2022
BUY
$5.86 - $9.43 $281,866 - $453,583
48,100 New
48,100 $446,000

Others Institutions Holding MIST

# of Institutions
45
Shares Held
28.7M
Call Options Held
200
Put Options Held
0
View Full List

About Milestone Pharmaceuticals Inc.

MIST Quotes by TradingView
  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $59.1M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email